Literature DB >> 4341440

A classification of the murine leukemia viruses. Neutralization of pseudotypes of Friend spleen focus-forming virus by type-specific murine antisera.

R J Eckner, R A Steeves.   

Abstract

Coinfection of neonatal BALB/c mice with helper-dependent Friend spleen focus-forming virus (SFFV), as contained in the Friend virus (FV) complex, and antigenically distinct Moloney leukemia virus (MolLV) resulted in the recovery of a MolLV pseudotype of SFFV, abbreviated SFFV(MolLV). The antigenic alteration of SFFV was observed by following its neutralization kinetics in vitro by specific Friend or Moloney typing antiserum. Effective pseudotype production was accomplished only when N-tropic LLV-F (the natural helper virus in the FV complex) was inhibited in B-type mice coinfected with an NB-tropic MolLV or other murine leukemia virus (MuLV) preparation. SFFV pseudotypes could not be prepared by using murine viruses other than leukemia viruses. SFFV prepared after two serial passages in the presence of MolLV was effectively neutralized by Moloney antiserum, but not by Friend typing antiserum; therefore, the envelope of the pseudotype virus, SFFV(MolLV), is homogeneous. Pseudotype virus was antigenically stable in the absence of continued mixed infection of BALB/c mice with SFFV(MolLV) and MolLV. However, SFFV(MolLV) was easily converted back to the LLV-F type after only one passage in BALB/c mice coinfected with NB-tropic LLV-F. The antigenic interconversion between LLV-F and MolLV types demonstrated that SFFV is defective with respect to the expression of neutralizable envelope antigens. Analysis of the neutralizable envelope antigens of nine SFFV(MuLV) pseudotypes by a panel of seven typing antisera made possible a "type-specific" SFFV(MuLV) envelope classification. Two major categories have been identified which correspond to the Gross (G) and Friend-Moloney-Rauscher (FMR) subgroups. Further, the FMR subgroup was divided into four types on the basis of distinct neutralization patterns. These results indicated that the specificity observed by cytotoxic G vs. FMR antisera is different from that observed by neutralization kinetics. We therefore suggest that the specific antigens revealed by virus neutralization tests be referred to as type specific.

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4341440      PMCID: PMC2139277          DOI: 10.1084/jem.136.4.832

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  43 in total

1.  Host-induced changes in infectivity of Friend spleen focus-forming virus.

Authors:  R A Steeves; R J Eckner
Journal:  J Natl Cancer Inst       Date:  1970-03       Impact factor: 13.506

2.  ASSAY FOR FRIEND LEUKEMIA VIRUS: RAPID QUANTITATIVE METHOD BASED ON ENUMERATION OF MACROSCOPIC SPLEEN FOCI IN MICE.

Authors:  A A AXELRAD; R A STEEVES
Journal:  Virology       Date:  1964-11       Impact factor: 3.616

3.  Development and serial cellfree passage of a highly potent strain of mouse leukemia virus.

Authors:  L GROSS
Journal:  Proc Soc Exp Biol Med       Date:  1957-04

4.  Chloroleukemia of mice.

Authors:  A GRAFFI
Journal:  Ann N Y Acad Sci       Date:  1957-10-21       Impact factor: 5.691

Review 5.  Envelope classification of avian RNA tumor viruses.

Authors:  P K Vogt
Journal:  Bibl Haematol       Date:  1970

6.  Neutralization of Graffi leukaemia virus.

Authors:  J P Levy; B Varet; E Oppenheim; J C Leclerc
Journal:  Nature       Date:  1969-11-08       Impact factor: 49.962

7.  The murine leukemia-sarcoma virus complex.

Authors:  R J Huebner
Journal:  Proc Natl Acad Sci U S A       Date:  1967-09       Impact factor: 11.205

8.  In vivo and in vitro recovery of defective Friend virus by various leukemia viruses.

Authors:  A H Fieldsteel; P J Dawson; C Kurahara
Journal:  Int J Cancer       Date:  1971-09-15       Impact factor: 7.396

9.  Host-range restrictions of murine leukemia viruses in mouse embryo cell cultures.

Authors:  J W Hartley; W P Rowe; R J Huebner
Journal:  J Virol       Date:  1970-02       Impact factor: 5.103

10.  Antigens of leukemias induced by naturally occurring murine leukemia virus: their relation to the antigens of gross virus and other murine leukemia viruses.

Authors:  G Geering; L J Old; E A Boyse
Journal:  J Exp Med       Date:  1966-10-01       Impact factor: 14.307

View more
  25 in total

1.  Induction of interferon and erythropoietic differentiation in cells transformed by Friend virus.

Authors:  P Swetly
Journal:  J Virol       Date:  1975-01       Impact factor: 5.103

2.  Defective Friend spleen focus-forming virus: interfering properties and isolation free from standard leukemia-inducing helper virus.

Authors:  R J Eckner; K L Hettrick
Journal:  J Virol       Date:  1977-10       Impact factor: 5.103

3.  Biological expression of antigenic determinants of murine leukemia virus proteins gp69-71 and p30.

Authors:  H Ikeda; T Pincus; T Yoshiki; M Strand; J T August; E A Boyse; R C Mellors
Journal:  J Virol       Date:  1974-11       Impact factor: 5.103

4.  Helper-dependent properties of Friend spleen focus-forming virus: effect of the Fv-1 gene on the late stages in virus synthesis.

Authors:  R J Eckner
Journal:  J Virol       Date:  1973-09       Impact factor: 5.103

5.  Structural proteins of mammalian oncogenic RNA viruses: multiple antigenic determinants of the major internal protein and envelope glycoprotein.

Authors:  M Strand; J T August
Journal:  J Virol       Date:  1974-01       Impact factor: 5.103

6.  Immunodiffusion analysis of mouse leukemia antigens.

Authors:  O M Lezhneva
Journal:  Bull Exp Biol Med       Date:  1974-11       Impact factor: 0.804

7.  Spontaneous regression of Friend virus-induced erythroleukemia. I. The role of the helper murine leukemia virus component.

Authors:  M Dietz; S P Fouchey; C Longley; M A Rich; P Furmanski
Journal:  J Exp Med       Date:  1977-03-01       Impact factor: 14.307

8.  Specific neutralization of defective spleen focus-forming virus in Friend virus complex by rat antiserum.

Authors:  C Yoosook; R A Steeves; S Ruscetti
Journal:  J Virol       Date:  1979-08       Impact factor: 5.103

9.  Spleen focus-forming virus: specific neutralization by antisera to certain gag gene-encoded proteins.

Authors:  R Anand; S Ruscetti; R A Steeves; F Lilly
Journal:  J Virol       Date:  1981-01       Impact factor: 5.103

10.  Structural proteins of mammalian oncogenic RNA viruses: murine leukemia virus neutralization by antisera prepared against purified envelope glycoprotein.

Authors:  R A Steeves; M Strand; J T August
Journal:  J Virol       Date:  1974-07       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.